Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results

References

• GruntzigARSenningASiegenthalerWENonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplastyN Engl J Med19793016168449946
   PubMed Web of Science ®Google Scholar
• AgemaWRJukemaJWPimstoneSNKasteleinJJGenetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapyEur Heart J2001222058207411686664
   PubMed Web of Science ®Google Scholar
• MoriceMCSerruysPWSousaJEA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med20023461773178012050336
   PubMed Web of Science ®Google Scholar
• SigwartUPuelJMirkovitchVJoffreFKappenbergerLIntravascular stents to prevent occlusion and restenosis after transluminal angioplastyN Engl J Med19873167017062950322
   PubMed Web of Science ®Google Scholar
• FischmanDLLeonMBBaimDSA randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study InvestigatorsN Engl J Med19943314965018041414
   PubMed Web of Science ®Google Scholar
• FattoriRPivaTDrug-eluting stents in vascular interventionLancet200336124724912547552
   PubMed Web of Science ®Google Scholar
• LemesleGMaluendaGCollinsSDWaksmanRDrug-eluting stents: issues of late stent thrombosisCardiol Clin2010289710519962052
   PubMedGoogle Scholar
• LemesleGPinto SlottowTLWaksmanRVery late stent thrombosis after bare-metal stent implantation: case reports and review of the literatureJ Invasive Cardiol200921273219126924
   PubMed Web of Science ®Google Scholar
• DaemenJWenaweserPTsuchidaKEarly and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort studyLancet200736966767817321312
   PubMed Web of Science ®Google Scholar
• JensenLOTilstedHHThayssenPPaclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart RegistryEuroIntervention2010589890520542774
   PubMed Web of Science ®Google Scholar
• JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol2006419320216814667
   PubMed Web of Science ®Google Scholar
• CookSLadichENakazawaGCorrelation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosisCirculation200912039139919620501
   PubMed Web of Science ®Google Scholar
• GargPMauriLThe conundrum of late and very late stent thrombosis following drug-eluting stent implantationCurr Opin Cardiol20072256557117921745
   PubMed Web of Science ®Google Scholar
• McFaddenEPStabileERegarELate thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyLancet20043641519152115500897
   PubMed Web of Science ®Google Scholar
• InoueTCroceKMorookaTSakumaMNodeKSimonDIVascular inflammation and repair, implications for re-endothelialization, restenosis and stent thrombosisJACC Cardiovasc Interv201141057106622017929
   PubMed Web of Science ®Google Scholar
• GargSSerruysPWNew concepts in the design of drug-eluting coronary stentsNat Rev Cardiol20131024826023419901
   PubMed Web of Science ®Google Scholar
• OtsukaFVorpahlMNakanoMPathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humansCirculation201412921122324163064
   PubMed Web of Science ®Google Scholar
• BriguoriCSaraisCPagnottaPIn-stent restenosis in small coronary arteries: impact of strut thicknessJ Am Coll Cardiol20024040340912142103
   PubMed Web of Science ®Google Scholar
• OrmistonJAWebsterMWRuygrokPNStent strut thickness and restenosisCirculation20021052E1211790719
   PubMed Web of Science ®Google Scholar
• TanigawaJBarlisPDimopoulosKDalbyMMoorePDi MarioCThe influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomographyInt J Cardiol200913418018818775576
   PubMed Web of Science ®Google Scholar
• HaraHNakamuraMPalmazJCSchwartzRSRole of stent design and coatings on restenosis and thrombosisAdv Drug Deliv Rev20065837738616650911
   PubMed Web of Science ®Google Scholar
• JukemaJWVerschurenJJAhmedTAQuaxPHRestenosis after PCI. Part 1: pathophysiology and risk factorsNat Rev Cardiol20119536221912414
   PubMed Web of Science ®Google Scholar
• SerruysPWOngATMoriceMCArterial Revascularisation Therapies Study Part II – Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesionsEuroIntervention2005114715619758896
   PubMedGoogle Scholar
• GrubeESilberSHauptmannKETAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesionsCirculation2003107384212515740
   PubMed Web of Science ®Google Scholar
• SerruysPWMoriceMCKappeteinAPSYNTAX InvestigatorsPercutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery diseaseN Engl J Med200936096197219228612
   PubMed Web of Science ®Google Scholar
• SabatéMJiménez-QuevedoPAngiolilloDJDIABETES InvestigatorsRandomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trialCirculation20051122175218316203930
   PubMed Web of Science ®Google Scholar
• KirtaneAJEllisSGDawkinsKDPaclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trialsJ Am Coll Cardiol20085170871518279734
   PubMed Web of Science ®Google Scholar
• SpauldingCHenryPTeigerETYPHOON InvestigatorsSirolimus-eluting versus uncoated stents in acute myocardial infarctionN Engl J Med20063551093110416971716
   PubMed Web of Science ®Google Scholar
• LaarmanGJSuttorpMJDirksenMTPaclitaxel-eluting versus uncoated stents in primary percutaneous coronary interventionN Engl J Med20063551105111316971717
   PubMed Web of Science ®Google Scholar
• MeredithITOrmistonJWhitbournRKayIPMullerDCutlipDEENDEAVOR I InvestigatorsFive-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human studyCatheter Cardiovasc Interv20097498999519859958
   PubMed Web of Science ®Google Scholar
• WiemerMSerruysPWMiquel-HebertKFive-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trialCatheter Cardiovasc Interv201075997100320517959
   PubMed Web of Science ®Google Scholar
• SerruysPWDaemenJAre drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stentsCirculation200711514331439 discussion 143917344323
   PubMed Web of Science ®Google Scholar
• JaffeRStraussBHLate and very late thrombosis of drug-eluting stents: evolving concepts and perspectivesJ Am Coll Cardiol20075011912717616295
   PubMed Web of Science ®Google Scholar
• BrilakisESPatelVGBanerjeeSMedical management after coronary stent implantation: a reviewJAMA20131018919823839753
   PubMed Web of Science ®Google Scholar
• StegPGJamesSKAtarDTask Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEur Heart J2012332569261922922416
   PubMed Web of Science ®Google Scholar
• MehtaSRYusufSPetersRJClopidogrel in Unstable Angina to Prevent Recurrent Events Trial (CURE) InvestigatorsEffects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyLancet200135852753311520521
   PubMed Web of Science ®Google Scholar
• SteinhublSRBergerPBMannJT3rdCREDO InvestigatorsClopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trialJAMA20022882411242012435254
   PubMed Web of Science ®Google Scholar
• WiviottSDBraunwaldEMcCabeCHTRITON-TIMI 38 InvestigatorsPrasugrel versus clopidogrel in patients with acute coronary syndromesN Engl J Med20073572001201517982182
   PubMed Web of Science ®Google Scholar
• WallentinLBeckerRCBudajAPLATO InvestigatorsTicagrelor versus clopidogrel in patients with acute coronary syndromesN Engl J Med20093611045105719717846
   PubMed Web of Science ®Google Scholar
• IakovouISchmidtTBonizzoniEIncidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsJAMA200522932126213015870416
   PubMed Web of Science ®Google Scholar
• EisensteinELAnstromKJKongDFClopidogrel use and long-term clinical outcomes after drug-eluting stent implantationJAMA200729715916817148711
   PubMed Web of Science ®Google Scholar
• ValgimigliMCampoGMontiMProlonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) InvestigatorsShort- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicentre trialCirculation20121252015202622438530
   PubMed Web of Science ®Google Scholar
• ParkSJParkDWKimYHDuration of dual antiplatelet therapy after implantation of drug-eluting stentsN Engl J Med20103621374138220231231
   PubMed Web of Science ®Google Scholar
• GwonHCHahnJYParkKWSix-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter studyCirculation201212550551322179532
   PubMed Web of Science ®Google Scholar
• KimBKHongMKShinDHRESET InvestigatorsA new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)J Am Coll Cardiol2012601340134822999717
   PubMed Web of Science ®Google Scholar
• CasseseSByrneRATadaTKingLAKastratiAClinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trialsEur Heart J2012333078308723091199
   PubMed Web of Science ®Google Scholar
• HawnMTGrahamLARichmanJSItaniKMHendersonWGMaddoxTMRisk of major adverse cardiac events following noncardiac surgery in patients with coronary stentsJAMA20133101462147224101118
   PubMed Web of Science ®Google Scholar
• KastratiAMehilliJDirschingerJIntracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trialCirculation20011032816282111401938
   PubMed Web of Science ®Google Scholar
• PacheJKastratiAMehilliJIntracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trialJ Am Coll Cardiol2003411283128812706922
   PubMed Web of Science ®Google Scholar
• SerruysPWOrmistonJAOnumaYA bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methodsLancet200937389791019286089
   PubMed Web of Science ®Google Scholar
• CostaJRJrAbizaidAFeresFEXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesionsEuroIntervention20084535819112779
   PubMedGoogle Scholar
• OrmistonJAMulticenter FIM study with a low dose elixir myolimus-eluting coronary stent system with a bioabsorable polymer: 6-month angiographic and IvUS resultsPresented at Transcatheter Cardiovascular Therapeutics (TCT)October 12–17, 2008Washington, DC
   Google Scholar
• JonerMNakazawaGFinnAVEndothelial cell recovery between comparator polymer-based drug-eluting stentsJ Am Coll Cardiol20085233334218652940
   PubMed Web of Science ®Google Scholar
• OstojicMSagicDBeleslinBFirst clinical comparison of Nobori Biolimus A9 eluting stents with Cypher sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomesEuroIntervention2008357457919608483
   PubMedGoogle Scholar
• HamilosMOstojicMBeleslinBDifferential effects of drug-eluting stents on local endothelium-dependent coronary vasomotionJ Am Coll Cardiol20082512123212918510958
   PubMed Web of Science ®Google Scholar
• HamilosMSarmaJOstojicMInterference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responsesCirc Cardiovasc Interv2008119320020031678
   PubMed Web of Science ®Google Scholar
• ChevalierBSilberSParkS-JRandomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberte paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial – phase 2Circ Cardiovasc Interv2009218819520031715
   PubMed Web of Science ®Google Scholar
• LemesleGSchurtzGDelhayeCBiolimus eluting stent with biodegradable polymer (Nobori®): an overview of recent clinical results, SORT OUT V and COMPARE II trialsExpert Rev Cardiovasc Ther2013111293129624090440
   PubMedGoogle Scholar
• ChristiansenEHJensenLOThayssenPScandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) V investigatorsBiolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT-OUT V): a randomized non-inferiority trialLancet201338166166923374649
   PubMed Web of Science ®Google Scholar
• SmitsPCHofmaSTogniMAbluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomized, controlled, non-inferiority trialLancet201338165166023374650
   PubMed Web of Science ®Google Scholar
• NatsuakiMKozumaKMorimotoTNEXT InvestigatorsBiodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trialJ Am Coll Cardiol20136218119023684673
   PubMed Web of Science ®Google Scholar
• SerruysPWFarooqVKalesanBImproved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease. Final 5-year report of the LEADERS trialJ Am Coll Cardiol Interv20136777789
   Web of Science ®Google Scholar
• StefaniniGGByrneRASerruysPWBiodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patient undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trialsEur Heart J2012331214122222447805
   PubMed Web of Science ®Google Scholar